Weight · appetite · metabolic healthGLP-1 Weight Management
Personalized medical weight management for appetite regulation, weight resistance, insulin resistance, and body-composition goals.
Treatment may include compounded GLP-1 medications (single-pathway GLP-1 or dual-pathway GLP-1/GIP) when prescribed and clinically appropriate. Compounded semaglutide and tirzepatide are not FDA-approved and are not generic versions of Wegovy®, Ozempic®, Mounjaro®, or Zepbound®.















